Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

The Next Generation of LAAC Device and Tailored Therapy

Presenter: Saibal Kar

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

Presentation TVT 2016

Will General Anesthesia Be Needed for Valve Therapy?

Presenter: Douglas C Shook

June 18, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation TVT 2015

3M for Alternative Access TAVR? Early Experience and Next Steps

Presenter: Sandra Lauck, David A. Wood, Philippe Genereux

June 06, 2015

Presentation TVT 2015

Should All Repositionable Valves Have Intraprocedural TEE?

Presenter: Ian T. Meredith

June 06, 2015

Presentation TVT 2015

Impact of Second-Generation TAVR on Preprocedural Imaging

Presenter: Hasan Jilaihawi

June 06, 2015

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

The Next Generation of LAAC Device and Tailored Therapy

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Minorities, Poorer Patients Missing Out on Structural Heart Care

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Will General Anesthesia Be Needed for Valve Therapy?

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

3M for Alternative Access TAVR? Early Experience and Next Steps

Should All Repositionable Valves Have Intraprocedural TEE?

Impact of Second-Generation TAVR on Preprocedural Imaging

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content